Hypothermia therapy: neurological and cardiac benefits

Cédric Delhaye1, Michael Mahmoudi, Ron Waksman

  • 1Department of Internal Medicine, Division of Cardiology, Washington Hospital Center, 110 Irving Street, Washington, DC 20010, USA.

Insights

Hypothermia therapy (HT) improves outcomes for cardiac arrest patients but lacks clear benefits for acute myocardial infarction. Guidelines recommend HT for specific cardiac arrest survivors, with ongoing research for broader applications.

Area of Science:

  • Cardiology
  • Neurology
  • Critical Care Medicine

Background:

  • Hypothermia therapy (HT) offers neuroprotective and cardioprotective effects.
  • Its efficacy is well-established in cardiac arrest (CA) patients with coma.
  • Evidence for HT in acute myocardial infarction (MI) is still developing.

Purpose of the Study:

  • To review the clinical evidence for hypothermia therapy in post-cardiac arrest and acute myocardial infarction.
  • To discuss the mechanisms of action, cooling techniques, and adverse effects of HT.

Main Methods:

  • Review of randomized controlled trials and observational studies on hypothermia therapy.
  • Analysis of clinical guidelines and expert recommendations.
  • Examination of physiological mechanisms and adverse event profiles.

Main Results:

  • Randomized studies confirm HT reduces mortality and improves neurological outcomes in cardiac arrest patients, leading to guideline recommendations.
  • Observational studies support the feasibility and early application of HT in various CA scenarios, including non-ventricular fibrillation CA and post-resuscitation shock.
  • Current clinical evidence does not support HT as a standard of care for acute myocardial infarction due to insufficient demonstrated net benefit.

Conclusions:

  • Hypothermia therapy is a recommended intervention for unconscious adult patients with spontaneous circulation after out-of-hospital cardiac arrest due to ventricular fibrillation.
  • Further research is needed to establish the role and net benefit of HT in patients with acute myocardial infarction.
  • Understanding HT's mechanisms, techniques, and adverse effects is crucial for its safe and effective clinical application.

Related Concept Videos

Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in response to an infection or illness.
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Thermoregulation01:26

Thermoregulation

The human body has a sophisticated thermoregulation system that employs negative feedback mechanisms to maintain an optimal core temperature. When the core temperature drops, peripheral and central thermoreceptors send signals to the hypothalamus, activating the heat-promoting center. This center triggers several responses aimed at increasing the core temperature. First, vasoconstriction reduces the flow of warm blood from internal organs to the skin so that the heat is not lost from the skin,...
Homeostatic Imbalances in Body Temperature01:19

Homeostatic Imbalances in Body Temperature

Hyperthermia occurs when the body's temperature becomes unusually high, often due to heat exposure, intense physical activity, or certain illnesses. This condition can create a dangerous cycle where elevated body temperature increases the metabolic rate, generating more heat and potentially leading to organ failure and brain damage. A severe form of hyperthermia, called heat stroke, can raise body temperature to life-threatening levels. Fever, on the other hand, is a controlled form of...